|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61,450.00 ARS | -1.95% |
|
-10.88% | -12.90% |
| 04:22pm | AstraZeneca, Bristol Myers Not Pursuing Merger Talks | MT |
| 04:04pm | AstraZeneca Pays CSPC $10 Million for Exercise of License Option for Pre-clinical Candidate Program | MT |
| Market Cap | 245B 366,570B 213B 198B 182B 344B 23,290B 348B 2,337B 914B 11,642B 919B 899B 38,575B | P/E 2026 * |
20.2x | P/E 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 265B 396,644B 230B 214B 197B 373B 25,200B 377B 2,529B 988B 12,597B 995B 973B 41,740B | EV / Sales 2026 * |
4.19x | EV / Sales 2027 * | 3.85x |
| Free-Float |
96.63% | Yield 2026 * |
2.11% | Yield 2027 * | 2.23% |
Last Transcript: AstraZeneca PLC
| 1 day | -1.95% | ||
| 1 week | -10.88% | ||
| Current month | -8.25% | ||
| 1 month | -23.19% | ||
| 3 months | -10.49% | ||
| 6 months | -13.30% | ||
| Current year | -12.90% |
| 1 week | 60,650 |  | 67,850 |
| 1 month | 60,650 | | 75,900 |
| Current year | 60,650 | | 80,275 |
| 1 year | 48,700 | | 80,275 |
| 3 years | 20,620 | | 80,275 |
| 5 years | 4,760.5 | | 80,275 |
| 10 years | 214.5 | | 80,275 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.95% | -10.88% | - | - | 245B | |
| -0.51% | -8.60% | +45.08% | +148.21% | 995B | |
| +0.20% | -4.42% | +49.05% | +50.81% | 614B | |
| -0.53% | -7.37% | +23.64% | +65.03% | 431B | |
| +1.24% | -0.17% | +41.39% | +36.34% | 353B | |
| +0.83% | -3.36% | +31.33% | +39.54% | 293B | |
| -5.64% | -14.08% | -5.05% | -46.77% | 210B | |
| +2.94% | -0.78% | +29.17% | +60.32% | 210B | |
| +3.13% | +0.69% | +18.11% | +71.90% | 168B | |
| +1.52% | +0.63% | +7.99% | -27.44% | 145B | |
| Average | +0.03% | -3.83% | +26.74% | +44.22% | 379.8B | |
| Weighted average by Cap. | +1.19% | -5.34% | +34.58% | +70.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.27B 94,721B 54.93B 51.22B 47.05B 88.99B 6,018B 89.96B 604B 236B 3,008B 238B 232B 9,968B | 66.84B 100,073B 58.04B 54.11B 49.71B 94.02B 6,358B 95.05B 638B 249B 3,178B 251B 246B 10,531B |
| Net income | 12.09B 18,094B 10.49B 9.78B 8.99B 17B 1,150B 17.19B 115B 45.09B 575B 45.38B 44.39B 1,904B | 13.71B 20,527B 11.9B 11.1B 10.2B 19.28B 1,304B 19.5B 131B 51.16B 652B 51.49B 50.36B 2,160B |
| Net Debt | 20.09B 30,074B 17.44B 16.26B 14.94B 28.25B 1,911B 28.56B 192B 74.95B 955B 75.43B 73.78B 3,165B | 12.3B 18,414B 10.68B 9.96B 9.15B 17.3B 1,170B 17.49B 117B 45.89B 585B 46.19B 45.17B 1,938B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/08/26 | ARS 61,450.00 | -1.95% | 1,865 |
| 03/08/26 | ARS 62,675.00 | -6.42% | 8,269 |
| 31/07/26 | ARS 66,975.00 | -0.07% | 51 |
| 30/07/26 | ARS 67,025.00 | -2.37% | 2,160 |
| 29/07/26 | ARS 68,650.00 | -0.44% | 453 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
